China NMPA Product Recall - Drug-eluting coronary stent systems and rapid exchange coronary stent systems
China NMPA product recall for Drug-eluting coronary stent systems and rapid exchange coronary stent systems by Medtronic Inc. published July 20, 2016. Recall level: . Medtronic Inc., supported by its Chinese entity Medtronic (Shanghai) Management Co., Ltd., initiated
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA product recall for Drug-eluting coronary stent systems and rapid exchange coronary stent systems by Medtronic Inc. published July 20, 2016. Recall level: . Medtronic Inc., supported by its Chinese entity Medtronic (Shanghai) Management Co., Ltd., initiated
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Company
Medtronic Inc.Inspection Date
Unknown Date
Product Type
ID: 414b6303-37a5-409e-8b99-09280cf891cd
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox